1 / 39

IN THE NAMEOF GOD

IN THE NAMEOF GOD. DR HAIDAR KHADEMI ASSISTANT PROFESSOR AND HEAD OF ORAL MEDICINE DEPARTMENT OF DENTAL SCHOOL OF ISFAHAN MEDICAL SCIENCES UNIVERSITY.IRAN. Determination of DMFT index in patients with ESRD being treated by hemodialysis in Ali Asghar medical center of. ISFAHAN.IRAN.

clarke
Télécharger la présentation

IN THE NAMEOF GOD

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. IN THE NAMEOF GOD

  2. DR HAIDAR KHADEMI ASSISTANT PROFESSOR AND HEAD OF ORAL MEDICINE DEPARTMENT OF DENTAL SCHOOL OF ISFAHAN MEDICAL SCIENCES UNIVERSITY.IRAN

  3. Determination of DMFT index in patients with ESRD being treated by hemodialysis in Ali Asghar medical center of ISFAHAN.IRAN

  4. There are 8 million people in the UNITED STATES today with some form of kidney disease.Of these,some 60000 die annually as a result of chronic,progressive,irreversible kidney failure(ESRD).Each year approximately 1.3 in 10000 develop ESRD,and this is increasing by about 10% per year ,most rapidly in patients over 65.ESRD is a bilateral,progressive,and chronic deterioration of nephrons that results in uremia and ultimately leads to death. Introduction

  5. RENAL FAILURE • ACUTE • CHRONIC

  6. Etiology of ESRD • Diabetes mellitus 44.4% • Hypertension26.6% • Glomerlunephritis 12.2% • Interstitial nephritis7.2 % • Other diseases 9.6%

  7. Systemic disturbances in RENAL DISEASE UREMIC SYNDROM • Gastrointestinal • Neuromuscular • Hematologic,immunologic • Endocrine metabolic • Cardiovascular • Dermatologic

  8. ORAL MANIFESTATIONS

  9. Enlarged(asymptomatic salivary glands) • Decreased salivary flow • Dry mouth • Odor of urea on breath • Metalic taste • Increased calcium formation • Low caries rate • Enamel hypoplasia • Dark brown stains on crowns • Dental malocclusion

  10. 11.Pale mucosa 12.Low grade gingival inflammation 13.Petechea and echymosis 14.Bleeding from gingiva 15.Prolonged bleeding 16.Candida infections 17.Burninig and tenderness of mucosa 18.Erosive glossitis 19.Tooth erosion (secondray to regugitation) 20.Dehiscence of wounds

  11. Radiographic • Deminralization of bone • Loss of bony trabeculation • Ground glass appearance • Loss of lamina dura • Giant cell lesions(brown tumors) • Sockets sclerosis • Pulpal narrowing and calcification • Tooth mobility • Arterial and oral calcification

  12. REVIEW OF LITRATURES1981 BUBLITEZ ENAMEL HYPOPLASIA IN2 GROUPS OF NEPHROTIC SYN {73} AND CRF (49).1982 DEFFEZ FRENCH. 1984 ORBY FRENCH LOWER DECAY IN ESRD HYPOPLASIA 2 TEETH. 1985 WOLF & PETERSON ENAMEL EFFECTS IN CHILDREN(60%) ESRD,CRF. 1989 GERMANY SCHEULTZEL 52% ENAMEL HYPOPLASIA.1991 ROJAS FRENCH1998 U.S.A

  13. OBJECTIVES • Despites these unfavorable factors,the recent researches indicated relatively lower DMFT index in these patients.Regarding these results ,this study was trying to identify the DMFT index. The study attempted to find out whether there was statistically meaningful difference between patients with ESRD being treated by hemodialysis,and healthy people.In addition ,the effect of factors,sex,the age of the beginning of hemodialysis treatment and duration of hemodialysis.

  14. METHODS • In this descriptive-analytic research,22 patients with ESRD being treated by hemodialysis were examined.This was the total number of the patients ranging from 17 to 33 years old who had reffered to ALI ASGHAR MEDICAL CENTER IN ISFAHAN during 2 months.After examining and indicating the DMFT index in these patients,they were compared with a healthy control group which were identical to the study group regarding their sex,age and number.

  15. Sampling was easy with no systemic disease except ESRD. 22 patients 16 were man and 6 women and divided in 4 groups. Patients <25 years old (6), between 20 to 25 (7), between 26 to 30 (7) and over 30 were 3 patients.

  16. RESULTS

  17. P=0.493 P>0.05 t-test TABLE 1: COMPARISON OF MEAN DMFT INDEX BETWEEN MAELS AND FEMAELS.

  18. DMFT SEX FIG 1

  19. TABLE 2: RELATION BETWEEN THE AGE OF DIALYSIS BEGINNING AND DMFT INDEX. P=0.8 P>0.05Tukey – HSD test (Analysis of variance)

  20. DMFT AGE OF DIALYSIS BEGINING FIG 2

  21. TABLE 3: RELATION BETWEEN THE DURATION OF DIALYSIS AND DMFT. P= 0.73 P> 0.05Tukey – HSD test (Analysis of variance)

  22. DMFT THE DURATION OF DIALYSIS FIG 3

  23. TABLE 4: COMPRISON OF DMFT INDEX IN ANTERIOR TOOTH IN 2 GROUPS(CASE-CONTROL). P=0.027 P<0.05 t-test

  24. DMFT FIG 4

  25. TABLE 5: COMPRAISON OF DMFT INDEX IN POSTRIOR TOOTH IN 2 GROUPS (CASE-CONTROL). P=0.007 P<0.05 t-test

  26. DMFT FIG 5

  27. TABLE 6: COMPARISON TOTAL DMFT INDEX IN 2 GROUPS (CASE-CONTROL). P=0.001 P<0.05 t-test

  28. DMFT FIG 6

  29. SIO-SE-POLE

  30. Discussion

  31. It was diagnosed that the patients with ESRD BEING TREATED BY HEMODIALYSIS HAD A NOTICEABLE,LOWER DMFT INDEX COMPARED TO THE NORMAL PEOPLE AND THIS DIFFERENCE IS MORE DISTINCT IN POSTERIOR TEETH.Further,despite the fact that no statitically meaningful relation was found between the age of beginning of hemodialysis treatment,the duration of hemodialysis treatment and the DMFT index of patientswith ESRD ,but it is probable that a direct relation existbetween the 2 above mentioned alternatives and the DMFT index in these patients in greater samples.

  32. THE END

More Related